These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36550317)

  • 1. Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients.
    Matsuo O; Ishii M; Kaikita K; Morinaga J; Miyamura F; Matsumoto S; Tsujita K; Nakamura K
    Pediatr Cardiol; 2023 Jun; 44(5):1150-1159. PubMed ID: 36550317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    Ito M; Kaikita K; Sueta D; Ishii M; Oimatsu Y; Arima Y; Iwashita S; Takahashi A; Hoshiyama T; Kanazawa H; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease.
    Mitsuse T; Kaikita K; Ishii M; Oimatsu Y; Nakanishi N; Ito M; Arima Y; Sueta D; Iwashita S; Fujisue K; Kanazawa H; Takashio S; Araki S; Usuku H; Suzuki S; Sakamoto K; Yamamoto E; Soejima H; Tsujita K
    J Atheroscler Thromb; 2020 Mar; 27(3):215-225. PubMed ID: 31391352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.
    Arima Y; Kaikita K; Ishii M; Ito M; Sueta D; Oimatsu Y; Sakamoto K; Tsujita K; Kojima S; Nakagawa K; Hokimoto S; Ogawa H
    J Thromb Haemost; 2016 Apr; 14(4):850-9. PubMed ID: 26773298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.
    Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejimaa H; Matsushita K; Tsujita K
    Thromb Res; 2021 Apr; 200():141-148. PubMed ID: 33610886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thrombogenicity is associated with revascularization outcomes in patients with chronic limb-threatening ischemia.
    Kuyama N; Kaikita K; Ishii M; Mitsuse T; Nakanishi N; Fujisue K; Otsuka Y; Hanatani S; Sueta D; Takashio S; Araki S; Yamamoto E; Matsushita K; Tsujita K
    J Vasc Surg; 2022 Aug; 76(2):513-522.e3. PubMed ID: 35390483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
    Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
    Kaikita K; Hosokawa K; Dahlen JR; Tsujita K
    Thromb Haemost; 2019 Oct; 119(10):1554-1562. PubMed ID: 31330558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of thrombosis and anticoagulation post Fontan surgery.
    Attard C; Huang J; Monagle P; Ignjatovic V
    Thromb Res; 2018 Dec; 172():204-213. PubMed ID: 29685556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.
    Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Matsushita K; Tsujita K
    Int J Cardiol; 2021 Feb; 325():121-126. PubMed ID: 33053391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Kikuchi S; Tsukahara K; Ichikawa S; Abe T; Minamimoto Y; Kimura Y; Akiyama E; Nakayama N; Okada K; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Circ J; 2020 May; 84(6):975-984. PubMed ID: 32188836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural Thrombogenicity Change Is Associated With Subclinical Leaflet Thrombosis Progression in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Kuyama N; Kaikita K; Ishii M; Tabata N; Oda S; Otsuka Y; Egashira K; Shirahama Y; Hanatani S; Takashio S; Matsuzawa Y; Yamamoto E; Hirai T; Tsujita K
    Circ Rep; 2023 Dec; 5(12):450-458. PubMed ID: 38073872
    [No Abstract]   [Full Text] [Related]  

  • 13. Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention.
    Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Yamamoto E; Soejima H; Matsushita K; Tsujita K
    Cardiovasc Interv Ther; 2023 Jul; 38(3):299-308. PubMed ID: 36877333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Late Thromboembolic Complications Post-Fontan Procedure in Relation to Different Antithrombotic Regimens: 30-Years' Follow-up Experience.
    Al-Jazairi AS; Al Alshaykh HA; Di Salvo G; De Vol EB; Alhalees ZY
    Ann Pharmacother; 2019 Aug; 53(8):786-793. PubMed ID: 30788973
    [No Abstract]   [Full Text] [Related]  

  • 15. Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Oimatsu Y; Kaikita K; Ishii M; Mitsuse T; Ito M; Arima Y; Sueta D; Takahashi A; Iwashita S; Yamamoto E; Kojima S; Hokimoto S; Tsujita K
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.
    Yamaguchi Y; Moriki T; Igari A; Matsubara Y; Ohnishi T; Hosokawa K; Murata M
    Thromb Res; 2013 Aug; 132(2):263-70. PubMed ID: 23777751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edoxaban Enhances Thromboprophylaxis by Physiotherapy After Total Knee Arthroplasty　- The Randomized Controlled ESCORT-TKA Trial.
    Sueta D; Kaikita K; Okamoto N; Yamabe S; Ishii M; Arima Y; Ito M; Oimatsu Y; Mitsuse T; Iwashita S; Nakamura E; Hokimoto S; Mizuta H; Ogawa H; Tsujita K;
    Circ J; 2018 Jan; 82(2):524-531. PubMed ID: 28924075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboprophylaxis strategies for children with single-ventricle circulations (superior or total cavo-pulmonary connections) after stent implantation.
    Ooi YK; Ligon RA; Kelleman M; Vincent RN; Bauser-Heaton HD; Kim DW; Petit CJ
    Cardiol Young; 2019 Jul; 29(7):877-884. PubMed ID: 31208476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
    McCrindle BW; Manlhiot C; Cochrane A; Roberts R; Hughes M; Szechtman B; Weintraub R; Andrew M; Monagle P;
    J Am Coll Cardiol; 2013 Jan; 61(3):346-53. PubMed ID: 23246393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation - The ATTRACTIVE-TTAS study.
    Ishii M; Kaikita K; Mitsuse T; Nakanishi N; Oimatsu Y; Yamashita T; Nagamatsu S; Tabata N; Fujisue K; Sueta D; Takashio S; Arima Y; Sakamoto K; Yamamoto E; Tsujita K
    Int J Cardiol Heart Vasc; 2019 Jun; 23():100346. PubMed ID: 30976651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.